Few have done more to shape Europe’s modern psychedelic research landscape than Professor Robert Schoevers, a psychiatrist and epidemiologist who is, among other things, Head of the Department of Psychiatry at University Medical Center Groningen and principal investigator of PsyPal, a large, EU-funded study of psilocybin in patients with palliative care needs. As a lead architect of that project…
